Bayan an kammala hadakar, ya kai dalar Amurka biliyan 2.4, da tsabar kudi kusan dalar Amurka miliyan 400. Ana sa ran cinikin zai samar wa HeartFlow jimlar kudaden shiga har zuwa dalar Amurka miliyan 599 don haɓaka haɓakar ci gaban gwajinsa na musamman na zuciya.
Shugaban HeartFlow, Shugaba da mai haɗin gwiwa John Stevens ya ce a cikin sanarwar manema labarai: "Mun yi imanin cewa ba mu da ƙarfi, tallafin fasaha na wucin gadi, mafitacin software na tushen girgije na iya wuce ƙimar haɗarin haɗari, Tsarin bincike da sarrafa jiyya don canza kulawar zuciya da jijiyoyin jini. ”. "Yana da mahimmanci cewa mun haɗu da ƙungiyar masu fasaha tare da ƙwarewa mai zurfi a cikin fasaha, likitancin zuciya, da kasuwancin kiwon lafiya, kuma mun himmatu don cimma wannan hangen nesa ga marasa lafiya. Na yi matukar alfahari da kungiyar HeartFlow ta kai wannan muhimmin ci gaba."
Ta hanyar wannan ma'amala, haɗin gwiwar kamfanin zai yi aiki a matsayin HeartFlow Group kuma ana sa ran za a siyar da shi a kasuwar hada-hadar hannayen jari ta New York a ƙarƙashin alamar HFLO.
"Mun yi farin cikin saka hannun jari tare da ma'aikatan HeartFlow, jagoranci, da masu hannun jari don inganta saurin karɓar ceton rayuwarsu, hanyoyin tantance zuciya na juyin juya hali," in ji Shugaban Longview Larry Robbins. "A gare mu, halayen zuba jarurruka na HeartFlow sun fito fili a kan takarda: ta hanyar tsarin kasuwanci mai ban sha'awa, kuma ta hanyar fasaha na fasaha don magance ɗimbin buƙatun likita da ba a cika su ba, masana gabaɗaya sun yi imanin cewa wannan ƙirar tana da ƙananan farashi Farashin Tsarin yana ba da sakamako mai kyau na haƙuri. .”
HeartFlow ya haɓaka bincike na FFRCT na HeartFlow, gwajin zuciya mara lalacewa ga marasa lafiya da ke da tsayayyen cututtukan jijiyoyin jini. FDA ta amince da ita a watan Satumba na 2019.
Kamfanin Redwood City, na California yana shirin faɗaɗa damar kasuwancin da za a iya magance shi zuwa fiye da dala biliyan 50 ta hanyar sabbin kayayyaki, ƙarin sabbin rukunin yanar gizon abokan ciniki, da kuma amfani da HeartFlow a cikin tsarin kiwon lafiya na yanzu.
Software na bincike na HeartFlow na iya ƙirƙirar ƙira na dijital da keɓaɓɓen ƙirar 3D na zuciya. Yana ba da kimar CTS-derived Fractional Flow Reserve (FFRCT) dabi'u tare da arteries na jijiyoyin jini don taimakawa likitoci su fahimci tsananin toshewar jijiyoyin jini wanda ke hana kwararar jini zuwa zuciya da kuma tantance mafi kyawun tsarin jiyya ga majiyyaci.
"Kungiyar HeartFlow ta himmatu wajen samar da mafi kyawun kulawa ga marasa lafiya na zuciya da kuma sanya wannan fasaha mai ban mamaki ta shahara," in ji William Weldon, Shugaban HeartFlow. "Haɗin kai tare da Longview da masu zuba jari na kamfanin za su inganta HeartFlow don ƙara taimakawa likitoci a cikin ganewar asali, gudanarwa da kuma samar da madaidaicin kulawa ga marasa lafiya na CAD."
Kafin cinikin HeartFlow, Longview ya jera hanyar sadarwa na Butterfly akan farashin dalar Amurka miliyan 859 a watan Fabrairun wannan shekara.
Ana sa ran kammala hadakar a cikin rubu'i na hudu na wannan shekara, inda ake jiran sharuddan al'ada da kuma amincewar hukumar hada-hadar hannayen jari ta Amurka.
An ƙaddamar da shi kamar haka: manyan bayanai, kasuwanci / labarai na kuɗi, na zuciya da jijiyoyin jini, fasali, zagaye na kuɗi, fasahar kiwon lafiya, sadaukarwar jama'a ta farko (IPO), software/IT Tagged tare da: HeartFlow, Longview Acquisition Company, SPAC
Haƙƙin mallaka © 2021 · WTWH Media LLC da masu ba da lasisi. duk haƙƙin mallaka. Ba tare da rubutaccen izini na WTWH Media ba, kayan da ke wannan gidan yanar gizon ba za a iya kwafi, rarrabawa, watsawa, cache ko akasin haka ba.
Lokacin aikawa: Dec-08-2021
